35 results
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
DOACs) for VTE treatment ... and prevention ... - Comparison Table ... Pharmacology #Comparison #Table
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... duration same as for treatment ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS Preventing ... Penicilliosis #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... Preventing First ... HumanPapillomavirus #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS Preventing ... Enteric #Bacterial #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... candida #mucosal #IDSA ... #Prevention #Treatment
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
Bethanechol • Used in treatment ... of urinary retention ... distention and urinary retention ... • Used In treatment ... #Pharmacology #Table
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... #Encephalitis #IDSA ... #Prevention #Treatment
Debridement and Management of Prosthetic Joint Infection (PJI)
Duration of symptoms <3 weeks OR  <30 days
Joint Infection (PJI ... Debridement & implant retention ... Cortes_Penfield #PJI ... Joint #Infection #treatment
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
IDSA Treatment Recommendations ... Maintenance Therapy Table ... Virus–Infected Individuals Table ... Transplant Recipients Table ... Meningoencephalitis #IDSA